UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

PloS one, 2009-03, Vol.4 (3), p.e4724-e4724

2009

Volltextzugriff (PDF)

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy

PLoS medicine, 2008-07, Vol.5 (7), p.e158-e158

2008

Volltextzugriff (PDF)

Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment

Antiviral therapy, 2008-01, Vol.13 Suppl 2 (2_suppl), p.25-36

2008

Volltextzugriff (PDF)

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model

The Lancet (British edition), 2008-04, Vol.371 (9622), p.1443-1451

2008

Volltextzugriff (PDF)

Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004

Antiviral therapy, 2008-01, Vol.13 Suppl 2 (2_suppl), p.101-107

2008

Volltextzugriff (PDF)

The World Health Organization's global strategy for prevention and assessment of HIV drug resistance

Antiviral therapy, 2008-01, Vol.13 Suppl 2 (2_suppl), p.1-13

2008

Volltextzugriff (PDF)

Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania

Antiviral therapy, 2008-01, Vol.13 Suppl 2 (2_suppl), p.77-82

2008

Volltextzugriff (PDF)

A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings

Antiviral therapy, 2008-01, Vol.13 Suppl 2 (2_suppl), p.37-48

2008

Volltextzugriff (PDF)

Prevalence of Tuberculosis Infection in the United States Population: The National Health and Nutrition Examination Survey, 1999-2000

American journal of respiratory and critical care medicine, 2008-02, Vol.177 (3), p.348-355

2008

Volltextzugriff (PDF)

HIV Drug Resistance Early Warning Indicators in Cohorts of Individuals Starting Antiretroviral Therapy Between 2004 and 2009: World Health Organization Global Report From 50 Countries

Clinical infectious diseases, 2012-05, Vol.54 (suppl_4), p.S280-S289

2012

Volltextzugriff (PDF)

World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites

Antiviral therapy, 2008-01, Vol.13 Suppl 2 (2_suppl), p.15-23

2008

Volltextzugriff (PDF)

DNA fingerprinting of Mycobacterium tuberculosis isolates from epidemiologically linked case pairs

Emerging infectious diseases, 2002-11, Vol.8 (11), p.1224-1229

2002

Volltextzugriff (PDF)

The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world

Current opinion in infectious diseases, 2006-12, Vol.19 (6), p.607-614

Bennett, Diane E

2006

Volltextzugriff (PDF)

World Health Organization Generic Protocol to Assess Drug-Resistant HIV Among Children <18 Months of Age and Newly Diagnosed With HIV in Resource-Limited Countries

Clinical infectious diseases, 2012-05, Vol.54 (suppl_4), p.S254-S260

2012

Volltextzugriff (PDF)

Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies

Antiviral therapy, 2008-01, Vol.13 Suppl 2 (2_suppl), p.59-68

2008

Volltextzugriff (PDF)

Identifying the sources of tuberculosis in young children: a multistate investigation

Emerging infectious diseases, 2002-11, Vol.8 (11), p.1216-1223

2002

Volltextzugriff (PDF)

A Retrospective Survey of HIV Drug Resistance Among Patients 1 Year After Initiation of Antiretroviral Therapy at 4 Clinics in Malawi

Clinical infectious diseases, 2012-05, Vol.54 (suppl_4), p.S355-S361

2012

Volltextzugriff (PDF)

Transmitted HIV Drug Resistance Among Drug-Naive Subjects Recently Infected With HIV in Mexico City: A World Health Organization Survey to Classify Resistance and to Field Test Two Alternative Patient Enrollment Methods

Clinical infectious diseases, 2012-05, Vol.54 (suppl_4), p.S328-S333

2012

Volltextzugriff (PDF)

Population-based monitoring of HIV drug resistance in Namibia with early warning indicators

Journal of acquired immune deficiency syndromes (1999), 2010-12, Vol.55 (4), p.27-31

2010

Volltextzugriff (PDF)

Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006

Antiviral therapy, 2008-01, Vol.13 Suppl 2 (2_suppl), p.95-100

2008

Volltextzugriff (PDF)

HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam

Antiviral therapy, 2008-01, Vol.13 Suppl 2 (2_suppl), p.115-121

2008

Volltextzugriff (PDF)

The World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: Global, Regional, and Country Progress

Clinical infectious diseases, 2012-05, Vol.54 (suppl_4), p.NP-NP

2012

Volltextzugriff (PDF)

World Health Organization Generic Protocol to Assess Drug-Resistant HIV Among Children <18 Months of Age and Newly Diagnosed With HIV in Resource- Limited Countries: The World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: Global, Regional, and Country Progress

Clinical infectious diseases, 2012, Vol.54

2012

Volltextzugriff (PDF)

A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings: Implementation of the World Health Organization's strategy for HIV drug resistance prevention and assessment in countries scaling up antiretroviral treatment

Antiviral therapy, 2008, Vol.13, p.37-48

2008

Volltextzugriff (PDF)

Transmitted HIV Drug Resistance Among Drug-Naive Subjects Recently Infected With HIV in Mexico City: A World Health Organization Survey to Classify Resistance and to Field Test Two Alternative Patient Enrollment Methods: The World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: Global, Regional, and Country Progress

Clinical infectious diseases, 2012, Vol.54

2012

Volltextzugriff (PDF)

1 – 25 von 194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(158)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy

Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model

Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004

The World Health Organization's global strategy for prevention and assessment of HIV drug resistance

Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania

A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings

Prevalence of Tuberculosis Infection in the United States Population: The National Health and Nutrition Examination Survey, 1999-2000

HIV Drug Resistance Early Warning Indicators in Cohorts of Individuals Starting Antiretroviral Therapy Between 2004 and 2009: World Health Organization Global Report From 50 Countries

World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites

DNA fingerprinting of Mycobacterium tuberculosis isolates from epidemiologically linked case pairs

The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world

World Health Organization Generic Protocol to Assess Drug-Resistant HIV Among Children <18 Months of Age and Newly Diagnosed With HIV in Resource-Limited Countries

Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies

Identifying the sources of tuberculosis in young children: a multistate investigation

A Retrospective Survey of HIV Drug Resistance Among Patients 1 Year After Initiation of Antiretroviral Therapy at 4 Clinics in Malawi

Transmitted HIV Drug Resistance Among Drug-Naive Subjects Recently Infected With HIV in Mexico City: A World Health Organization Survey to Classify Resistance and to Field Test Two Alternative Patient Enrollment Methods

Population-based monitoring of HIV drug resistance in Namibia with early warning indicators

Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006

HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam

The World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: Global, Regional, and Country Progress

World Health Organization Generic Protocol to Assess Drug-Resistant HIV Among Children <18 Months of Age and Newly Diagnosed With HIV in Resource- Limited Countries: The World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: Global, Regional, and Country Progress

Suchergebnisse filtern